Impact of a co-factor on the dynamics ofLeishmania donovaniinfection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis?
Authors:
- A. NandyANA. Nandy
- M. AddyMAM. Addy
- A.K. MajiAMA.K. Maji
- S.K. GuhaSGS.K. Guha
- 1 September 2004
- journal article
- case report
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 98 (6) , 651-654
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Treatment of leishmaniasis in HIV-positive patientsPathogens and Global Health, 2003
- HIV-Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin BAIDS, 1999
- Recurrence of kala‐azar after PKDL: role of co‐factorsTropical Medicine & International Health, 1998
- Subpopulations of T Lymphocytes in the Peripheral Blood, Dermal Lesions and Lymph Nodes of Post Kala‐azar Dermal Leishmaniasis PatientsScandinavian Journal of Immunology, 1995
- Recurrent cutaneous leishmaniasis: A role for persistent parasites?Parasitology Today, 1994
- Leishmania infantum Tropism: Strain genotype or host immune status?Parasitology Today, 1994
- Leishmanin test survey in an endemic village of Indian kala-azar near CalcuttaPathogens and Global Health, 1987